Results From IMPROVE Study Show Therapeutic Effect of New Formulation of Rebif(R) at 16 Weeks in Patients With Multiple... (ts treated with the newformulation of Re...)

HOME >> MEDICINE >> NEWS

Results From IMPROVE Study Show Therapeutic Effect of New Formulation of Rebif(R) at 16 Weeks in Patients With Multiple Sclerosis

Date:9/21/2008

ts treated with the new formulation of Rebif(R) had zero combined unique active brain lesions at week 16, compared to only 16.7% in the placebo group.

Results for the secondary and tertiary endpoints of the IMPROVE study will be available at the end of the 40-week treatment period.

The safety profile of the new formulation of Rebif(R) reported in this study is consistent with the known safety profile of Rebif(R). No unexpected safety concerns were identified in this study.

The new formulation of Rebif(R) was approved in the European Union in August 2007 and in Canada in September 2007. It is now marketed in all EU countries and in Canada. The new formulation of Rebif(R) is not available in the United States.

About Rebif(R)

Rebif(R) (interferon beta-1a) is a disease-modifying drug used to treat relapsing forms of multiple sclerosis (MS) and is similar to the interferon beta protein produced by the human body. The efficacy of Rebif(R) in chronic progressive MS has not been established. Interferons are thought to help modulate the body's immune system and reduce inflammation. The exact mechanism is unknown.

Rebif(R), which was approved in Europe in 1998 and in the US in 2002, is registered in more than 80 countries worldwide. Rebif(R) has been proven to delay the progression of disability, reduce the frequency of relapses and reduce MRI lesion activity and area.* Rebif(R) is available in a 22 micrograms and 44 micrograms ready-to-use pre-filled syringe and a titration pack (8.8 micrograms).

Rebif(R) should be used with caution in patients with a history of depression, liver disease and seizures. Most commonly reported side effects are flu-like symptoms, injection site disorders, elevation of liver enzymes and blood cell abnormalities. Patients, especially those with depression, seizure disorders, or liver problems, should discuss treatment with Rebif(R) with their doctors. For more information about Rebif(R), please visi
'/>"/>

SOURCE Merck Serono
Copyright©2008 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2 3 4 5
Related medicine news :

1. Haemacure Reports Third Quarter 2007 Results
2. Brooke Franchise Corporation Announces Selected July Results
3. AKELA Pharma Inc. announces positive results for the extension part of its Phase IIb Fentanyl TAIFUN(R) trial
4. Somanetics Corporation to Release Third Quarter 2007 Financial Results and Host Conference Call September 19
5. The New England Journal of Medicine Publishes EURIDIS/ADONIS Study Results Showing Dronedarone Maintained Sinus Rhythm in Patients With Atrial Fibrillation or Flutter With no Observed Pro-Arrhythmia
6. NBTY Announces Preliminary Unaudited Net Sales Results For August 2007
7. Martek Announces Third Quarter 2007 Financial Results
8. MDS Reports Third Quarter 2007 Results
9. Authentidate Holding Corp. to Report Fourth Quarter and Fiscal 2007 Year End Results on Thursday, September 13, 2007
10. Robbins & Myers to Release Fourth Quarter and 2007 Fiscal Year Results on Monday, October 15, 2007
11. NMHC Reports Fourth Quarter and Fiscal Year 2007 Financial Results

Post Your Comments:

(Date:5/24/2013)... May 24, 2013 In a coup that ... Greg DeLange of the Estetica Institute of the Palm ... KOOL 105.5 FM’s popular morning show, “The Mo & Sally ... experiences and their satisfaction with the results, giving Dr. DeLange ... located in Palm Beach Gardens, very valuable free publicity. , ...

(Date:5/24/2013)... CBT News.com recently announced the addition of Tom ... automotive industry news organization with 12 years experience in online ... a group that’s so forward-thinking in their approach,” says Gonter. ... content is on the rise.” , Atlanta born and raised, ... into advertising at Cycle News and Boating World. He made ...

(Date:5/24/2013)... 24, 2013 The Institute for Integrative ... announce that it has donated $10,000 to the Cleveland ... captive in Cleveland, Ohio. , “When the news came out ... and Amanda Berry and her daughter had escaped from a ... were shocked and horrified,” said Integrative Nutrition Founder, Director, and ...

(Date:5/24/2013)... 24, 2013 The point-of-care (POC) ... used outside the central laboratory, by other healthcare ... practitioner or by consumers. This includes products that ... pregnancy, infectious and cardiovascular disease and cancer, as ... critical care, surgical and emergency departments. , Critical ...

(Date:5/24/2013)... first conference of its kind, Impacts World 2013 ... decision makers from politics, business and civil society ... climate impact research across sectors and scales. , ... 2013 on May 27th, 1pm to 1:55pm and ... Speakers include: , Connie Hedegaard, EU ...

Breaking Medicine News(10 mins):Health News:Dr. Greg DeLange of the Estetica Institute Recently Performed Eye Surgery on Both Members of Popular Morning Radio Team 2 Health News:Integrative Nutrition Donates $10,000 to the Cleveland Courage Fund 2 Health News:Point of Care Diagnostics Market (POC) Analysis and 5 Year Forecast in New Research Report at ReportsnReports.com 2 Health News:Point of Care Diagnostics Market (POC) Analysis and 5 Year Forecast in New Research Report at ReportsnReports.com 3

[0] Dr. Greg DeLange of the Estetica Institute Recently Performed Eye Surgery on Both Members of Popular Morning Radio Team [0] Tom Gonter to Drive Sales at Retail Automotive News Organization CBT News [0] Integrative Nutrition Donates $10,000 to the Cleveland Courage Fund [0] Point of Care Diagnostics Market (POC) Analysis and 5 Year Forecast in New Research Report at ReportsnReports.com [0] Impacts conference on climate change effects

... , , FRANKLIN ... (NYSE: MHS ), the world,s most advanced pharmacy(R) ... into a joint venture with United Drug plc, a Pan-European healthcare ... for patients covered by the country,s National Health Service (NHS). ...

... , MARINA DEL RAY, Calif., Aug. 12 Dr. ... to welcome Italian students from the University of L,Aquila by assisting ... school is being rebuilt after the devastating April 5th earthquake in ... who were displaced by the earthquake in L,Aquila, Italy, including the ...

... ISELIN, N.J., Aug. 12 Pharmos Corporation (Pink Sheets: PARS) today reported financial ... , Second Quarter Ended June 30, 2009 , ... or $0.05 per share, for the second quarter 2009 compared to a net ... Cash and cash equivalents totaled $2.9 million at June 30, 2009. , ...

... have given for years , WEDNESDAY, Aug. 12 (HealthDay News) ... painful swelling of the arm that often occurs after breast ... to what women have been told for years -- that ... other exercise because muscle strain can cause lymphedema to worsen. ...

... Goal is to help patients who might benefit from ... By clarifying rules governing patient access to so-called investigational ... to expand the number of people who might benefit ... can get the drugs hasn,t changed, but there is ...

... , WASHINGTON, Aug. 12 During a town ... stated his opposition to legislation that would cover illegal aliens. Specter ... was the author of the 2006 amnesty bill (S. 2611) that ... illegal aliens under the proposed reforms is a clear indication of ...

Medco Health Solutions, United Drug Announce U.K. Homecare Pharmacy Joint Venture Serving Patients with Chronic and Complex Health Conditions; Innovations to Improve Clinical Quality, Reduce Costs Heritage Provider Network and Dr. Richard Merkin Come to the Aid of Italian Earthquake Victims Pharmos Corporation Reports 2009 Second Quarter Results Weight Lifting Can Ease Arm Swelling in Breast Cancer Survivors FDA Details Access to 'Investigational' Drugs Specter Promises to Oppose Health Care Reform That Covers Illegal Aliens

(Date:5/23/2013)... Md. , May 23, 2013 BioElectronics Corporation ... consumer medical devices, comments on the FDA panel meeting ... Advisory Panel Reclassification – Pulsed Shortwave Therapy Meeting was ... MD , USA. The focus of the meeting ... the panel to focus solely on the application of ...

(Date:5/23/2013)... Medical Systems, Inc. (NASDAQ: CASM ) (CASMED), a ... that Thomas M. Patton , President and ... Annual Marcum MicroCap Conference on Thursday, May 30, 2013, at ... . The presentation is scheduled to begin ... will be available via a live webcast at http://wsw.com/webcast/marcum/casm/ ...

(Date:5/23/2013)... , May 23, 2013 Halozyme ... announced the appointment of David A. ... Ramsay was most recently Vice President, Corporate Development ... ) "With his established financial management ... gained by working in our commercial group for ...

Breaking Medicine Technology:BioElectronics and Pulsed Shortwave Therapy Make Progress 2 CASMED to Present at the 2nd Annual Marcum MicroCap Conference 2 Halozyme Therapeutics Names David A. Ramsay Chief Financial Officer 2

[0] BioElectronics and Pulsed Shortwave Therapy Make Progress [0] CASMED to Present at the 2nd Annual Marcum MicroCap Conference [0] Halozyme Therapeutics Names David A. Ramsay Chief Financial Officer

... ... ... ... ...

Cached Medicine Technology:Diabetics Twice as Likely to Have Hearing Loss; California HearUSA Centers to Offer Free Hearing Screening and Diabetes Video in March 2 Diabetics Twice as Likely to Have Hearing Loss; California HearUSA Centers to Offer Free Hearing Screening and Diabetes Video in March 3 Diabetics Twice as Likely to Have Hearing Loss; California HearUSA Centers to Offer Free Hearing Screening and Diabetes Video in March 4 Diabetics Twice as Likely to Have Hearing Loss; California HearUSA Centers to Offer Free Hearing Screening and Diabetes Video in March 5 Diabetics Twice as Likely to Have Hearing Loss; California HearUSA Centers to Offer Free Hearing Screening and Diabetes Video in March 6 Diabetics Twice as Likely to Have Hearing Loss; California HearUSA Centers to Offer Free Hearing Screening and Diabetes Video in March 7 Biomedical Advanced Research and Development Authority (BARDA) Project for Radiation Exposure Research Awarded to SRI International 2 Biomedical Advanced Research and Development Authority (BARDA) Project for Radiation Exposure Research Awarded to SRI International 3 Biomedical Advanced Research and Development Authority (BARDA) Project for Radiation Exposure Research Awarded to SRI International 4 Biomedical Advanced Research and Development Authority (BARDA) Project for Radiation Exposure Research Awarded to SRI International 5 Biomedical Advanced Research and Development Authority (BARDA) Project for Radiation Exposure Research Awarded to SRI International 6 Biomedical Advanced Research and Development Authority (BARDA) Project for Radiation Exposure Research Awarded to SRI International 7

Diabetics Twice as Likely to Have Hearing Loss; California HearUSA Centers to Offer Free Hearing Screening and Diabetes Video in March Biomedical Advanced Research and Development Authority (BARDA) Project for Radiation Exposure Research Awarded to SRI International

For the qualitative detection of single and multiple drugs and drug metabolites in human urine...

Medicine Products:

AMPII BZO300 COC MAMPII MOP THC SureStep Morphine (MOP)THC COC MOP AMPII MAMPII BZO200 SureStep MOP AMPII THC COC BZO200